Alyssa Mitson-Salazar
Clinical FellowDownloadHi-Res Photo
Cards
Contact Info
About
Copy Link
Titles
Clinical Fellow
Biography
Last Updated on December 09, 2022.
Appointments
Rheumatology
Clinical FellowPrimary
Other Departments & Organizations
Education & Training
- PhD
- Yale University, Immunobiology (2024)
- MD
- Yale University, Immunobiology (2024)
- MPhil
- Yale University
- BS
- Yale University
Research
Copy Link
Research at a Glance
Publications Timeline
A big-picture view of Alyssa Mitson-Salazar's research output by year.
5Publications
16Citations
Publications
2022
Environmental sensing mechanisms in intestinal homeostasis
Mitson-Salazar A, Medzhitov R. Environmental sensing mechanisms in intestinal homeostasis. The Journal Of Allergy And Clinical Immunology 2022, 150: 577-579. PMID: 35820536, DOI: 10.1016/j.jaci.2022.06.019.Commentaries, Editorials and LettersCitationsAltmetric
2017
Pathogenic Effector Th2 Cells in Allergic Eosinophilic Inflammatory Disease.
Mitson-Salazar A, Prussin C. Pathogenic Effector Th2 Cells in Allergic Eosinophilic Inflammatory Disease. Front Med (Lausanne) 2017, 4: 165. PMID: 29057225, DOI: 10.3389/fmed.2017.00165.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2016
Rapamycin preferentially inhibits human IL-5+ TH2-cell proliferation via an mTORC1/S6 kinase-1–dependent pathway
Yin Y, Mitson-Salazar A, Wansley D, Singh S, Prussin C. Rapamycin preferentially inhibits human IL-5+ TH2-cell proliferation via an mTORC1/S6 kinase-1–dependent pathway. Journal Of Allergy And Clinical Immunology 2016, 139: 1701-1704.e10. PMID: 27923564, DOI: 10.1016/j.jaci.2016.10.029.Peer-Reviewed Original ResearchCitationsMeSH KeywordsAdultAntigens, DermatophagoidesAntigens, ViralCell ProliferationCells, CulturedDose-Response Relationship, DrugFemaleHumansImmunosuppressive AgentsInterleukin-5Lymphocyte ActivationMaleMechanistic Target of Rapamycin Complex 1Middle AgedRespiratory Syncytial VirusesRibosomal Protein S6 KinasesSignal TransductionSirolimusTh2 CellsYoung AdultHematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function.
Mitson-Salazar A, Yin Y, Wansley DL, Young M, Bolan H, Arceo S, Ho N, Koh C, Milner JD, Stone KD, Wank SA, Prussin C. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol 2016, 137: 907-18.e9. PMID: 26431580, DOI: 10.1016/j.jaci.2015.08.007.Peer-Reviewed Original Research
2015
Detection of Intracellular Cytokines by Flow Cytometry.
Yin Y, Mitson-Salazar A, Prussin C. Detection of Intracellular Cytokines by Flow Cytometry. Curr Protoc Immunol 2015, 110: 6.24.1-6.24.18. PMID: 26237012, DOI: 10.1002/0471142735.im0624s110.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
Copy Link
Honors
honor NIH Ruth L. Kirschstein National Research Service Award (NRSA) F30AI145102
09/15/2019National AwardNIH/NIAIDDetailsUnited States
Get In Touch
Copy Link